Pfizer’s Debt Concerns Cast Doubt on Viking Therapeutics Acquisitionby Mark Eisenberg 01.04.2024Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
Amazon Joins Dow Jones, Walgreens Booted – Bloombergby Mark Eisenberg 21.02.2024Amazon.com is set to join the Dow Jones Industrial Average, replacing Walgreens Boots Alliance, while Uber Technologies will replace JetBlue ...
Sosei Heptares: Strategic Wins Propel Growthby Mark Eisenberg 13.02.2024Sosei Group Corporation announces operational activities and consolidated results, including significant investment, marketing approval, and partnerships. Despite revenue decrease, the ...
Imaging Specialists and Pfizer Join Forces for AI-Driven Cardiac Amyloidosis Assessmentsby Lilu Anderson 11.01.2024Ultromics and Pfizer partner to advance AI detection of cardiac amyloidosis, aiming to revolutionize the management of the condition. FDA ...
Investors Reap Massive Gains in J&J’s Acquisition of Ambrxby Terry Bingman 09.01.2024Johnson & Johnson's acquisition of Ambrx showcases the power of biotech M&A, rewarding investors with staggering returns and highlighting the ...
Amiti Ventures Joins AION Labs as Strategic Partnerby John Darbie 08.01.2024AION Labs partners with Amiti Ventures to revolutionize precision medicine and drive biotech innovation. #AI #drugdiscovery #healthcare
Johnson & Johnson vs. Pfizer: Pharmaceutical Industry SWOTby Mark Eisenberg 21.08.2023The competition between Johnson & Johnson and Pfizer in the pharmaceutical industry is heating up. Here's a SWOT analysis of ...